Founded in Chengdu Zongheng Science Park in early 2022, GC Biotech is a high-tech enterprise focusing on the entrusted development and production organization (cdmo) platform of preventive biological products. We bring high-quality products to the market through efficient R & D system and low-cost production capacity. Serve the peers of biological products through technical cooperation, technical consultation and joint development. We aim to establish an open biotechnology student platform to make greater contributions to accelerating the development of the entire biotechnology and preventive biological products industry, so as to achieve a win-win situation among all participating partners in the industry. At present, the company has established bacterial vaccine technology platform, viral vaccine technology platform, combined vaccine technology platform, gene recombinant protein technology platform, mRNA technology platform, adjuvant technology platform, etc., and has established a core R & D team from well-known domestic scientific research institutions and biological products companies. By making full use of its rich R & D experience, the company is committed to developing innovative vaccines to effectively prevent various infectious diseases, Develop and produce candidate vaccines to respond to known or emerging disease threats. At the same time, we can also provide enterprises, scientific research institutions and medical institutions with self-developed laboratory reagents, verification reagents and professional service guidance. Jicang bio always adheres to innovation, makes breakthroughs, adheres to international standards, and achieves quality first and reputation first. I will mount a long wind some day and break the heavy waves, and set my cloudy sail straight and bridge the deep, deep sea!
At present, the company has established bacterial vaccine technology platform, viral vaccine technology platform, combined vaccine technology platform, gene recombinant protein technology platform, mRNA technology platform, adjuvant technology platform, etc., and has established a core R & D team from well-known domestic scientific research institutions and biological products companies. By making full use of its rich R & D experience, the company is committed to developing innovative vaccines to effectively prevent various infectious diseases, Develop and produce candidate vaccines to respond to known or emerging disease threats. At the same time, we can also provide enterprises, scientific research institutions and medical institutions with self-developed laboratory reagents, verification reagents and professional service guidance. GC Biotech always adheres to innovation, makes breakthroughs, adheres to international standards, and achieves quality first and reputation first. I will mount a long wind some day and break the heavy waves, and set my cloudy sail straight and bridge the deep, deep sea!
